[1] BURSZTYN M.Left ventricular hypertrophy in hypertension and nocturnal blood pressure[J].J Clin Hypertens(Greenwich),2015,17(12):914-915.
[2] WATROBA M,SZUKIEWICZ D.The role of sirtuins in aging and age-related diseases[J].Adv Med Sci,2015,61(1):52-62.
[3] LAWLER P R,HIREMATH P,CHENG S.Cardiac target organ damage in hypertension:insights from epidemiology[J].Curr Hypertens Rep,2014,16(7):446.
[4] VELASCO M,ISRAILI Z.Hypertension:from epidemiology to therapeutics[J].J Hypertens,2012,2012:908431.
[5] SACK M N.The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging[J].J Mol Cell Cardiol,2012,52(3):520-525.
[6] SUNDARESAN N R,GUPTA M,KIM G,et al.Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice[J].J Clin Invest,2009,119(9):2758-2771.
[7] PILLAI V B,SUNDARESAN N R,KIM G,et al.Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway[J].J Biol Chem,2010,285(5):3133-3144.
[8] LANZA I R,SHORT D K,SHORT K R,et al.Endurance exercise as a countermeasure for aging[J].Diabetes,2008,57(11):2933-2942.
[9] ZENG L,YANG Y,HU Y,et al.Age-related decrease in the mitochondrial sirtuin deacetylase Sirt3 expression associated with ROS accumulation in the auditory cortex of the mimetic aging rat model[J].PLoS One,2014,9(2):e88019.
[10] KENDRICK A A,CHOUDHURY M,RAHMAN S M,et al.Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation[J].Biochem J,2011,433(3):505-514.
[11] JING E,EMANUELLI B,HIRSCHEY M D,et al.Sirtuin-3(Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production[J].Pro Natl Acad Sci U S A,2011,108(35):14608-14613.
[12] HAFNER A V,DAI J,GOMES A P,et al.Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy[J].Aging,2010,2(12):914-923. |